Boots pre-close
This article was originally published in The Rose Sheet
Executive Summary
Boots Healthcare International second half sales jump about 13% at comparable exchange rates, UK company reports March 27 in a fiscal 2003 (ending March 31) 1pre-close statement. Clearasil sales continue to improve in response to increased marketing support and launches of new product lines, Boots states. Firm currently is rolling out Clearasil Total Control, a non-acne skin care line expected to generate $32 mil. in first year U.S. sales (2"The Rose Sheet" Dec. 16, 2002, p. 3). As part of company's increasing focus on core businesses, Boots the Chemists and Boots Healthcare International, Boots will exit Pure Beauty concept, which currently consists of six stores in the UK, firm says...